Company news
KalVista Pharmaceuticals, Inc. news in 2023
KalVista Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.
KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology
December 19, 2023
KalVista Pharmaceuticals Presents Real-World Data at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology
November 13, 2023
KalVista Pharmaceuticals Announces Phase 3 KONFIDENT Trial Milestone Achieved
November 12, 2023
KalVista Pharmaceuticals to Present Data at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology
November 1, 2023
KalVista Pharmaceuticals Presents Data on HAE Attacks in Patients Receiving Long-Term Prophylaxis at the Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2023 International Conference
October 23, 2023
KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference
September 18, 2023
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 HAEi Regional Conference EMEA
August 27, 2023
KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Nicole Sweeny as Chief Commercial Officer
July 24, 2023
KalVista Pharmaceuticals Presents New HAE Attack Journey Data at 2023 US HAEA National Summit
July 23, 2023
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 US HAEA National Summit
July 13, 2023
KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology
June 11, 2023
KalVista Pharmaceuticals to Present Data at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology (EAACI)
June 1, 2023
KalVista Pharmaceuticals to Present at Jefferies Global Healthcare Conference
May 30, 2023
KalVista Pharmaceuticals to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day Virtual Conference
May 22, 2023
KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop
May 7, 2023
KalVista Pharmaceuticals to Present Data at the 13th C1-inhibitor Deficiency & Angioedema Workshop
April 26, 2023
KalVista Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results
March 8, 2023
KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
February 26, 2023
KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology
February 15, 2023
KalVista Pharmaceuticals Provides Progress Updates on Sebetralstat Development
February 13, 2023
KalVista Pharmaceuticals Announces Publication of Sebetralstat Phase 2 Data in The Lancet
February 9, 2023
KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session
February 6, 2023
KalVista Pharmaceuticals to Present at SVB Securities Global Biopharma Conference
February 2, 2023
KalVista Pharmaceuticals Announces Benjamin L. Palleiko Promoted to President
January 4, 2023
Decks in 2023
- Technical Presentation (May 2023)
Technical · 13 slides · May 2023
- Technical Presentation (May 2023)
Technical · 14 slides · May 2023